Lifestyle and pharmacological management are not sufficient to control
BP in resistant hypertensive patients. Recently, invasive procedures
like renal sympathetic denervation or carotid baroreceptor stimulation
have represented new frontiers in the treatment of this condition.
Along with this, our findings demonstrate a new potent, non-invasive
and cheaper procedure that significantly reduces systolic and diastolic
BPs in this population. The beneficial effects on BP that were observed
in true and white-coat hypertension have important clinical consequences,
because both conditions are associated with higher cardiovascular
risk. It has been estimated that 5.0/2.0 mm Hg reductions in
systolic and diastolic BPs, respectively, result in a 6% to 14% reduction
in cardiovascular events